A Study on the Use of TanakanĀ® for Recovery of Neurological Impairment Following Ischaemic Stroke

Completed

Phase 3 Results N/A

Summary of Purpose

The purpose of this study is to evaluate the effectiveness of TanakanĀ® 240mg in association with Acetylsalicylic acid (325mg/day) in the recovery of neurological impairment following ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 17 January 2017.

1 Feb 2003 12 Jan 2006 1 Mar 2009 1 Mar 2009 1 Jan 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions See All

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available